Childhood cancer survivors have a persistent risk of subsequent leukemia beyond 10 years, especially with high ...

Tattoos may increase the risk of certain NHLs, particularly mature B-cell types, after 10 years or more. The study's small ...

With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...

Matias Sanchez, MD, assistant professor in the Department of Medicine, Division of Hematology and Oncology, University of Illinois Chicago, emphasizes the importance of patient education and caregiver ...

Palliative care is quality care, and providers and health systems need to do a better job at ensuring there is equity in ...

Food insecurity is a significant public health concern that disproportionately affects marginalized communities, contributing ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...